Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Pulse Biosciences (PLSE).
Pulse Biosciences, Inc. has made significant board changes, electing Paul A. LaViolette as a director and appointing him to various leadership roles, including co-chairman and head of the new Strategic Advisory Committee. LaViolette, a seasoned healthcare executive with 40 years of experience, also received stock options as part of his non-employee director compensation. The company revised its compensation policy for non-employee directors, enhancing cash and equity compensation to align with their increased responsibilities and committee service.
For an in-depth examination of PLSE stock, go to TipRanks’ Stock Analysis page.
